Heparin and osteoporosis during pregnancy: 2002 update

G Ruiz-Irastorza; M A Khamashta; G R V Hughes

Heparin and osteoporosis during pregnancy: 2002 update

G Ruiz-Irastorza, M A Khamashta, G R V Hughes

Women & Children's Health

Research output: Contribution to journal › Conference paper

23 Citations (Scopus)

Abstract

Although significant bone mass loss is rare during pregnancy, some situations may increase the risk of symptomatic osteoporosis. Heparin may be necessary for a number of pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may be a higher risk period for women at risk for osteoporosis.

Original language	English
Pages (from-to)	680 - 682
Number of pages	3
Journal	Lupus
Volume	11
Issue number	10
Publication status	Published - 2002
Event	3rd International Conference on Sex Hormones Pregnancy and the Rheumatic Disease - NEW ORLEANS, LOUISIANA Duration: 1 Jan 2002 → …

Cite this

@article{0f17e2f2df314442af7bad073956763a,

title = "Heparin and osteoporosis during pregnancy: 2002 update",

abstract = "Although significant bone mass loss is rare during pregnancy, some situations may increase the risk of symptomatic osteoporosis. Heparin may be necessary for a number of pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may be a higher risk period for women at risk for osteoporosis.",

author = "G Ruiz-Irastorza and Khamashta, {M A} and Hughes, {G R V}",

year = "2002",

language = "English",

volume = "11",

pages = "680 -- 682",

journal = "Lupus",

publisher = "SAGE Publications Ltd",

number = "10",

note = "3rd International Conference on Sex Hormones Pregnancy and the Rheumatic Disease ; Conference date: 01-01-2002",

}

TY - JOUR

T1 - Heparin and osteoporosis during pregnancy: 2002 update

AU - Ruiz-Irastorza, G

AU - Khamashta, M A

AU - Hughes, G R V

PY - 2002

Y1 - 2002

N2 - Although significant bone mass loss is rare during pregnancy, some situations may increase the risk of symptomatic osteoporosis. Heparin may be necessary for a number of pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may be a higher risk period for women at risk for osteoporosis.

AB - Although significant bone mass loss is rare during pregnancy, some situations may increase the risk of symptomatic osteoporosis. Heparin may be necessary for a number of pregnant women with systemic lupus erythematosus and antiphospholipid syndrome. The osteopenic effect of heparin is low even during pregnancy, and recent data point to a more favourable profile of low-molecular-weight heparins as compared with unfractionated heparin. Lactation results in a significant increase of calcium demands and may be a higher risk period for women at risk for osteoporosis.

UR - http://www.scopus.com/inward/record.url?scp=0036029898&partnerID=8YFLogxK

M3 - Conference paper

VL - 11

SP - 680

EP - 682

JO - Lupus

JF - Lupus

IS - 10

T2 - 3rd International Conference on Sex Hormones Pregnancy and the Rheumatic Disease

Y2 - 1 January 2002

ER -

Heparin and osteoporosis during pregnancy: 2002 update

Abstract

Other files and links

Fingerprint

Cite this